-
Researchers have successfully increased survival rates in pancreatic cancer mouse models by blocking a key pathway in the immune system, which more than doubled survival.
Mar 31,2022
-
UC San Diego study detects tell-tale proteins released into circulation by cancer cells
Mar 22,2022
-
Florida-based Singh Biotechnology is developing a new treatment approach that can shut off the “master switch” that controls cancer growth. This could revolutionize how we treat deadly cancers like pancreatic.
Mar 21,2022
-
The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, in association TGen, HonorHealth and Irish biomedical firm initiate promising ‘Nieto’ clinical trial against pancreatic cancer Named for a respected […]
Mar 21,2022
-
In a mouse study, a ketogenic diet tripled survival time compared with chemotherapy alone.
Mar 11,2022
-
Scientists in Spain and Germany have identified a genetic signature of 27 microbiome organisms in stool samples that can identify people at high risk of pancreatic ductal adenocarcinoma (PDAC), the […]
Mar 10,2022
-
A research team led by scientists at Roswell Park Comprehensive Cancer Center may have made a significant breakthrough in treating pancreatic cancer, according to a press release published by the institute on Wednesday.
Mar 07,2022
-
Lustgarten and the Salk Institute announced a new strategic partnership supported by a $5 million grant and focused on identifying and validating potential targets for new pancreatic cancer drugs.
Feb 22,2022
